| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.036 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.9 |